Blueprint Medicines' Partnership

Blueprint Medicines raised a round of funding on March 03, 2015. Investors include Alexion Pharmaceuticals.

Blueprint Medicines is a patient-driven oncology company discovering and developing highly selective kinase inhibitors for genomically defined cancers. Led by a management team and advisors with world…

Articles about Blueprint Medicines' Partnership: